Curcumin, a natural antioxidant, acts as a noncompetitive inhibitor of human RNase L in presence of its cofactor 2-5A in vitro

Biomed Res Int. 2014:2014:817024. doi: 10.1155/2014/817024. Epub 2014 Sep 2.

Abstract

Ribonuclease L (RNase L) is an antiviral endoribonuclease of the innate immune system, which is induced and activated by viral infections, interferons, and double stranded RNA (dsRNA) in mammalian cells. Although, RNase L is generally protective against viral infections, abnormal RNase L expression and activity have been associated with a number of diseases. Here, we show that curcumin, a natural plant-derived anti-inflammatory active principle, inhibits RNase L activity; hence, it may be exploited for therapeutic interventions in case of pathological situations associated with excess activation of RNase L.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / administration & dosage
  • Crystallography, X-Ray
  • Curcumin / administration & dosage*
  • Curcumin / chemistry
  • Endoribonucleases / antagonists & inhibitors
  • Endoribonucleases / biosynthesis*
  • Endoribonucleases / chemistry
  • Gene Expression Regulation, Developmental / drug effects*
  • Humans
  • Immunity, Innate / drug effects*
  • Molecular Docking Simulation
  • Protein Conformation / drug effects
  • RNA, Double-Stranded / genetics

Substances

  • Antioxidants
  • RNA, Double-Stranded
  • Endoribonucleases
  • 2-5A-dependent ribonuclease
  • Curcumin